Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-12-015796
Filing Date
2012-03-19
Accepted
2012-03-19 13:22:37
Documents
2
Period of Report
2012-03-19

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v306483_6k.htm 6-K 19422
2 GRAPHIC image_001.jpg GRAPHIC 2728
  Complete submission text file 0001144204-12-015796.txt   24338
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 12700013
SIC: 2834 Pharmaceutical Preparations